Abstract
INTRODUCTION
The European Society of Thoracic Surgeons (ESTS) registry is an online platform collecting data about thoracic surgery procedures across Europe and managed by the ESTS (http://www.ests. org/collaboration/database_registration_form.aspx).
The data collection started in 2007 and since then the registry has undergone radical transformations, becoming a completely online database with a dedicated storing server and organized in a central data set (lung module) with 4 satellite appendixes (the thymic module, the neuro endocrine tumor (NET) module, the mesothelioma module and the chest wall module).
The ultimate goals of the ESTS database are to improve the quality of care and to support the development of educational projects in our specialty.
The contribution to the registry is voluntary and every thoracic surgery unit with at least 1 staff surgeon being a member of the ESTS can prospectively upload data using the dedicated online web page (http://www.ests.org/collaboration/database_registra tion_form.aspx). At the same time, once a year, the ESTS registry imports offline large amount of data retrieved from the French National Database, and, on a regular basis, it also captures data from other international registries, such as the Hungarian National Database, and individual units that utilize their own databases.
Nowadays, the ESTS registry includes 170 active (i.e. more than 100 procedures uploaded, with a constant contribution for more than 2 years) European contributors, collecting data from 22 different countries. The cumulative number of procedures uploaded showed a constant rise over the years, and, at the end of 2015, more than 100 000 cases were stored within the database (Fig. 1) .
The aim of the present study was to provide an overview of the surgical activity as resulting from the analysis of the ESTS registry considering the central lung resection module, with a particular focus on characteristics and outcomes of anatomical lung resection performed to treat primary and secondary lung cancer.
MATERIALS AND METHODS
We downloaded from the ESTS registry storing system (containing a total amount of 105 867 procedures) all the lung procedures collected from the beginning of data collection (July 2007) through November 2016. These procedures account for 78.4% of the total cases uploaded into the registry (Fig. 1) .
The retrieved data (forming the 'ESTS_Data Base_lung_2016' for this study) underwent a process of data cleaning before the analytic phase. In particular, a data quality evaluation was performed to assess the rate of completeness and reliability of the core variables [1] present within the ESTS_DB_lung_2016. The completeness and reliability measurements were obtained following a standardized methodology [2] . All those variables with a combined completeness or reliability rate under 80% were excluded from the analysis. The high-quality variables adopted in this study are reported in Supplementary Material, Appendix S1 with their definition and acronyms explanation.
Among the 83 035 lung procedures of the ESTS_DB_lung_2016, we selected a cohort of 62 774 patients submitted to lung resection for primary or secondary lung cancer. For this study, we defined the metastatic lung cancer as secondary lung cancer. This definition was in line with the one used within the ESTS registry that adopted the terminology of secondary lung cancer as reported by the UK National Health Service (http://www.nhs. uk/conditions/Cancer-of-the-lung/Pages/Introduction.aspx). Figure 1 summarizes the patient selection process and the major steps of the analysis. We initially described the baseline characteristics and the type of surgery for the entire cohort of lung cancer patients in our base of data (see Section 1 of analysis and results).
After that, within the subpopulation of 51 931 patients affected by primary lung cancer, we verified the pathological stage of disease and the strategy adopted to stage preoperatively the mediastinal lymph nodes. Four different groups of patients were identified: Group 1-no lymph node enlargement at computed tomography (CT) scan and no lymph node detection at positron emission tomography (PET) scan; Group 2-lymph node enlargement at CT scan and no lymph node detection at PET scan; Group 3-lymph node enlargement at CT scan or lymph node detection at PET scan and Group 4-lymph node enlargement at CT scan and lymph node detection at PET scan. For each group, as a measure of the quality of the process, we verified the rate of patients submitted to an invasive procedure of mediastinal staging and the consequent results (Section 2 of analysis and results).
Finally, we analysed the impact of some potential risk factors on 30-day or in-hospital mortality and cardiovascular and pulmonary morbidity of those patients submitted to anatomical lung resection (lobectomy, pneumonectomy, bilobectomy and segmentectomy) for primary or secondary lung cancer (51 756 patients). For this study, the cardiovascular and pulmonary complications were defined in line with previous studies [3, 4] as follows: respiratory failure, need for reintubation, prolonged mechanical ventilation >24 h, pneumonia, atelectasis requiring bronchoscopy, pulmonary oedema, pulmonary embolism, acute respiratory distress syndrome/acute lung injury, arrhythmia requiring treatment, acute myocardial ischaemia, acute cardiac failure, stroke/transient ischaemic attacks and acute kidney injury (Section 3 of analysis and results).
The comparison between categorical variables and morbidity and mortality rates within this section of the analysis was performed using the v 2 test.
RESULTS
From July 2007 to November 2016, 75 529 lung resections were collected in total within the ESTS registry from 170 different contributors worldwide. As reported in Fig. 2 , 13% of these procedures were performed for benign diseases (non-neoplastic) and 4% for benign neoplasms. The remaining 82% of cases were operated for primary or secondary malignant lung cancer (51 931 primary lung cancers, 69%; 10 843 secondary lung cancers, 14%).
Section 1
The baseline characteristics of these 62 774 patients affected by primary or secondary malignant lung cancer are reported in Table 1 . Within this cohort, one-third of patients were women. The median age was 64 years [interquartile range (IQR) 57, 71]; of the total patients, 9314 patients were older than 74 years (14.8%) and 2656 were octogenarians (4.2%). More than one-third of the patients had some form of cardiac comorbidity. The most frequent cardiac comorbidities registered were hypertension, coronary artery disease and arrhythmia. In particular, a history of coronary artery disease was documented in 3642 patients (5.8% of the entire population). Among the other comorbidities, chronic kidney disease influencing an abnormal rise of the creatinine level was registered in 7.2% of patients. The American Society of Anesthesiologists (ASA) distribution showed that more than half of the patients were in Class 2 (mild systemic disease) (32 397 patients, 53.3%). In the entire cohort, the median predicted postoperative forced expiratory volume in 1 s (ppoFEV 1 ) was 73.3% (IQR 59, 87.6) of the predicted value. The shortest postoperative stay was registered for patients submitted to video-assisted thoracic surgery (VATS) lobectomy (median 6 days, IQR 4, 8) and the longest for the ones treated by pneumonectomy (median 9.5 days, IQR 7, 13). Figure 3 shows the distribution of the different types of resection used for treating primary and secondary lung cancers. Most of the patients with primary lung cancer were submitted to pulmonary lobectomy (71.8%), whereas pneumonectomy was reserved for 10.4% of this population. Wedge resections were performed for primary lung cancer in only 8.2% of cases. On the contrary, wedge resections were the most frequent treatment for secondary lung cancer (63.2%). Nevertheless, more than onethird of these patients needed an anatomical lung resection for treating a secondary neoplasm.
The proportion of the open surgery and VATS approach within each type of resection is reported in Fig. 4 . Twenty-one percent of the procedures for treating lung cancers were performed by VATS. Most of them were lobectomies and wedge resections. In particular, 18.2% of lobectomies and 44.5% of wedge resections were carried out using the VATS approach. The preoperative staging strategy of mediastinal lymph nodes in patients with primary lung cancer is described in Table 3 . The proportion of patients with an invasive assessment of the lymph nodes varied according to the findings at CT and PET scans. Seventy percent of patients were submitted to a preoperative invasive mediastinal staging in case both CT scan and PET scan were suggestive of clinical N2 disease. In about one-third of these patients, the final pathological finding was positive for nodal metastasis.
Section 2
If we consider the subgroup of patients with CT scan or PET scan suggestive of clinical N2 disease, invasive mediastinal staging was performed in 59.9% of cases.
Section 3
A total of 51 756 individuals were submitted to an anatomical lung resection for primary or secondary lung cancer. This population had an overall cardiopulmonary complication rate of 18.5% (9599 patients) and a 30-day mortality rate of 2.6% (1351 patients). Table 4 reports the incidence of cardiopulmonary complications and 30-day mortality in relation to several potential risk factors. Patients submitted to pneumonectomy and bilobectomy had the worst outcomes [pneumonectomy mortality: 6.7% (CI: 6, 7.3), morbidity: 26.4% (CI: 25.2, 27.6); bilobectomy mortality: 4.1% (CI: 3.6, 5.3), morbidity: 26.5% (CI: 24.7, 28.2)]. The rate of 30-day mortality for patients submitted to lobectomy for lung cancer was 2% (CI: 1.9, 2.1) and their cardiopulmonary morbidity rate was 17.6% (CI: 17.3, 18).
Elderly patients (age > _75 years) had higher rate of complications and mortality. In particular, the mortality was 2-fold higher in the elderly patients compared with younger patients [age > _75 years mortality: 4.6% (CI: 4.2, 5.1), age <75 years mortality: 2.3% (CI: 2.1, 2.4)]. The presence of at least 1 cardiac comorbidity increased the patient's mortality risk by about 1 point in percentage from 2.3% (CI: 2.2, 2.5) in patients without cardiac comorbidity to 3.2% (CI: 2.9, 3.4) in patients with associated cardiac comorbidities.
Patients with a lower ppoFEV 1 had an increased rate of cardiopulmonary complication and a doubled rate of mortality in comparison to those with a ppoFEV 1 > _70 [mortality rate ppoFEV 1 > _70: 1.8% (CI: 1.6, 2) vs mortality rate ppoFEV 1 <70: 3.5% (CI: 3.2, 3.7)].
The minimally invasive surgical approach was characterized by a lower incidence of both cardiopulmonary complications and 30-day mortality when compared with the open technique. In particular, the VATS patients registered the lowest mortality (1.1%, CI: 0.9, 1.4) within all the categories analysed in this population.
DISCUSSION
Since its inception, the purpose of the ESTS database was to monitor the surgical activity and outcomes in our specialty to improve the quality of care and promote educational projects for optimizing the clinical practice at the European level.
In this regard, the ESTS registry represents a solid base of data for 3 different lines of research and for a large quality-of-care assessment programme.
The first line of research consists in the development of risk models to adjust for the outcomes of lung resection [5, 6] . In this field, the last article published in 2016 proposed 2 different risk models to model the cardiopulmonary morbidity and 30-day mortality in patients submitted to anatomical lung resections for cancer. Both risk models have been shown to reliably predict the observed outcomes registered in the ESTS registry. The variables associated with the outcomes were gender, age, ppoFEV 1 , history of coronary artery disease or cerebrovascular disease or chronic kidney disease, surgical approach and extended resection for the morbidity.
The variables used for developing the models were gender, age, ppoFEV 1 , history of coronary artery disease or cerebrovascular disease, body mass index, surgical approach, pneumonectomy and extended resection for the mortality. Some of these variables were tested also in the present analysis confirming their importance for risk stratification [4] . The second line of research is the development of instruments and indicators for evaluating the quality of care in lung cancer surgery [4, 7] . In particular, we developed a multiparametric score incorporating processes and risk-adjusted outcome indicators (the composite performance score) that has been used to monitor the performance of thoracic surgery units at different levels. The process indicators currently included in the composite performance score are the rate of patients who had their diffusing capacity of the lungs for carbon monoxide (DLCO) measured before surgery, the rate of patients with clinical N2 disease who underwent any type of preoperative invasive mediastinal nodal staging and the proportion of patients submitted to a systematic lymph nodes dissection according to the ESTS published guidelines. The outcome indicators currently included in the composite score are the risk-adjusted mortality and cardiopulmonary morbidity. In this study, we explored the performance of the entire cohort of patients collected within the ESTS registry in relation to some of these indicators.
The third line of research is the development of methods for assessing the quality of data in multi-institutional and international databases [1, 2] . In particular, the methods developed to assess the quality of data in terms of completeness and reliability were applied in the data cleaning phase of this study before the data mining.
The knowledge derived from the aforementioned studies is currently applied in the ESTS quality certification programme for the accreditation of thoracic surgery units using specific professional, procedural and quality-of-care evaluation criteria (http:// www.ests.org/_userfiles/pages/files/DB%20session-accreditation %20Lisbon%202015.pdf).
This study provides an up-to-date overview of the information collected within the ESTS registry and regarding the lung resection procedures. Even though the analytical process did not explore in detail each of the several aspects of surgical care for patients with lung cancer, the results reported could be considered a solid benchmark to compare the activities and outcomes of single institutions in Europe and worldwide.
Principal findings
The most relevant results obtained from this analysis are summarized below:
1. The ESTS registry represents nowadays one of the largest international bases of data collecting more than 75 000 lung resection procedures, and more than 60 000 lung resections performed for primary or secondary lung cancer. Among them, 82% (51 756) were represented by anatomical lung resections (lobectomy, pneumonectomy, bilobectomy and segmentectomy). 2. The cohort of lung cancer patients submitted to resection and collected in our registry was for two-thirds represented by men, at variance with the most recent epidemiological studies showing an increasing incidence of lung cancer in women, with the prevalence very close to the one observed in men [8] . 3. The median age of this population was quite young (64 years, IQR: 57, 71), even though 9314 patients were older than 75 years. This factor should be taken into consideration in future studies addressing the outcomes in the elderly patients.
In the common clinical practice, as registered in our database, patient older than 75 years are commonly represented (14.8%), but the ones older than 80 years are still a minority (4.2%). 4. A large amount of patients submitted to lung resection for malignant lung neoplasm (more than 21 000, about one-third of our cohort) had at least another underlying comorbidity. , which is in line with a previously published study from the ESTS database [9] . As expected, the longest postoperative stay was observed after pneumonectomy (median 9.5 days, IQR: 7, 13), a finding which was likely explained by the high incidence of cardiopulmonary complication in these patients (26.4%, CI: 25.2, 27.6). 8. More than half of our patients were operated on for Stage I lung cancer, but 935 of them (1.8%) had a Stage IIIB disease, potentially indicating a deficit in the preoperative staging system. 9. Only 60% of patients treated by an anatomical resection for primary lung cancer and with clinical N2 disease documented by CT or PET scans underwent a procedure of invasive mediastinal staging as recommended by the ESTS [10] . This low rate indicates a field for developing educational activities promoted by the ESTS. 10. Thirty percent of primary lung cancer patients were not submitted to a preoperative lymph node invasive mediastinal staging procedure, despite CT scan showing nodal enlargement and PET scan detecting mediastinal nodal uptake. This means that 364 patients (29.7% of patients of the Group 4, as reported in Table 3 ) were directly submitted to lung resection with a high risk of metastatic disease to mediastinal lymph nodes. This could result in an under-staging of 109 patients with potential mediastinal lymph node metastasis, considering the fact that the rate of patient with a preoperative positive specimen in this group was 30.4% (Table 3) . 11. In the cohort of patients submitted to anatomical lung resection for cancer (primary or secondary), the overall cardiopulmonary morbidity was 18.5% and the overall 30-day mortality was 2.6%. Several factors seemed to influence both the outcomes: type of resection, age, presence of cardiac comorbidity, ppoFEV 1 and surgical approach. Accordingly, a young patient (age <75 years), without cardiac comorbidities and with a ppoFEV 1 > _70%, submitted to a VATS lobectomy for lung cancer had a cardiopulmonary complication rate of 9% and a 30-day mortality rate of only 0.7% (2020 patients, 4% of the entire database cohort had these favourable conditions). On the other hand, an old patient (age > _75 years), with cardiac comorbidity and with a low ppoFEV 1 submitted to an open lobectomy had a cardiopulmonary complication rate of 32.2% (rising at 40% in case of pneumonectomy) and a 30-day mortality rate of 5.2% (rising at 14.2% in case of pneumonectomy).
Limitations
This study has the potential following limitations:
1. Data collected within the ESTS registry are periodically submitted to processes of indirect data quality assessment, but they are not extensively and directly audited to verify their correspondence to the original data source and to the real world that they are intended to represent. Just a small proportion of them are verified systematically in terms of direct data quality using as comparative tools the original electronic or on paper documents of those units that entered the ESTS quality certification programme. 2. We excluded from the present analysis some potential interesting factors (i.e. DLCO), as they had a completeness below the limits set in the methods. The ppoDLCO value was reported for 14 879 patients of the 62 774 (completeness rate: 23.7%). The median ppoDLCO was 73.1%. 3. The procedures registered within the ESTS registry could have a non-homogeneous distribution in terms of countries, volume of activity and epidemiological scenario of the contributors. 4. Since the base of data used for the present study collects procedures spanning 10 years of activity, the analysis could underestimate the influence of time on the epidemiological characteristics of the patients as well as on the clinical practice and its results.
Clinical implications
This study offers a reliable overview of the clinical practice inherent to patients submitted to pulmonary resection for lung cancer as derived from data collected by more than 170 thoracic surgery units within the ESTS registry. The epidemiological and baseline characteristics of this large cohort, the information about the clinical practice and the reported outcomes represent a solid benchmark to compare the surgical activity performed by institutions and surgeons in our specialty.
This study could be used as an accepted standard of reference during the planning phase of further analyses at an international as well as at a local level and for the interpretation of the obtained results.
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Supplementary material is available at EJCTS online.
